Patients with tumor size ≥4 cm had increased raw CD31 (p = 0.006) and an increased PSMA/CD31 ratio (p = 0.038) compared to patients with tumor sizes <4 cm in greatest dimension grossly. This evidence concerns the gene FOLH1 and neoplasm.